Sandoz starts with Zessly in Germany

  
Generate a summary of this article
Listen to this article
Beta

Germany has become the launch market for Sandoz’Zessly (infliximab) biosimilar after the company’s Hexal affiliate introduced the rival to Merck Sharp & Dohme’s (MSD’s) Remicade on 15 November. Launch list prices for Zessly 100mg powder for concentrate range from €705.29 (US$804.00) for one 100mg vial to €3,467.28 for a pack of five, representing a modest 5% discount to MSD’s list price for Remicade.

Germany has become the launch market for Sandoz’Zessly (infliximab) biosimilar after the company’s Hexal affiliate introduced the rival to Merck Sharp & Dohme’s (MSD’s) Remicade on 15 November. Launch list prices for Zessly 100mg powder for concentrate range from €705.29 (US$804.00) for one 100mg vial to €3,467.28 for a pack of five, representing a modest 5% discount to MSD’s list price for Remicade.

Sandoz secured European Commission approval for Zessly earlier this year (Generics bulletin, 1 June 2018, page 14), putting Sandoz’ biosimilar...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Archive

ADHD Medications and Cardiovascular Effects: New Data Revealed. (A Comprehensive Evaluation of Emerging Clinical and Epidemiological Evidence on the Cardiovascular Effects Associated with Prescribed Medications for Attention Deficit Hyperactivity Disorder) - Clone - Clone

 
• By Nabil

A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.

Testing-Rising

 
• By Saba Afreen

Testing-Rising xxxx

bhvyuguig

lnkbkb

test 1

test 1

More from Generics Bulletin

GB-Business-Free-Podcast-The Secret to Walking More: It’s Not Counting Steps - Clone

 
• By Nabil

We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.